
|Videos|October 24, 2017
Role for Proton Therapy in Locally Advanced Non–Small-Cell Lung Cancer?
Author(s)Zhongxing Liao, MD
This video reviews results of a randomized trial comparing intensity modulated radiation therapy vs passively scattered proton therapy for locally advanced non–small-cell lung cancer.
Advertisement
In this video, Zhongxing Liao, MD, of MD Anderson Cancer Center in Houston, Texas, reviews results of a randomized trial that compared intensity modulated radiation therapy (IMRT) vs passively scattered proton therapy in patients with locally advanced non–small-cell lung cancer.
Liao gave a presentation on this topic earlier this year at the 2017 Multidisciplinary Thoracic Cancers Symposium.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Sunvozertinib Improves PFS vs Chemotherapy in EGFR+ NSCLC
2
FDA Clears Investigator-Initiated IND for SRN-101 in Recurrent High-Grade Glioma
3
The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes
4
Selinexor Combo Improves Spleen Volume Reduction in Myelofibrosis
5























































